Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gastric Cancer

Free Subscription Articles published in Eur J Surg Oncol Retrieve available abstracts of 130 articles: HTML format

Single Articles

September 2025
1. PAN S, Zhu W, Zhang Y, Zhang R, et al
   Contour-like model for precision risk stratification in gastric cancer patients underwent neoadjuvant therapy: A multicenter retrospective study.
   Eur J Surg Oncol. 2025;51:110455.
   PubMed     Abstract available
   
   
   
2. ZHENG CY, Huang XL, Wu J, Qiu XT, et al
   Prognostic impact of myopenia and establishment of a nomogram for predicting survival following radical gastrectomy in patients with gastric cancer: A multicenter study.
   Eur J Surg Oncol. 2025;51:110450.
   PubMed     Abstract available
   
   
   
3. ZHANG H, Tao S, Luo Y, Lu M, et al
   Impact of nutrition, comorbidity and complication on long term survival in gastric cancer following laparoscopic radical gastrectomy: A 10-year cohort study.
   Eur J Surg Oncol. 2025;51:110442.
   PubMed     Abstract available
   
   
   
4. WANG Y, Liu X, Zhang X, Fan P, et al
   Impact of sarcopenic obesity on postoperative complications and long-term survival in patients with gastric cancer.
   Eur J Surg Oncol. 2025;51:110437.
   PubMed     Abstract available
   
   
   August 2025
5. TANG X, Wang X, Man C, Zhang S, et al
   The role of gut microbiota in the perioperative management of gastric cancer and intervention methods: A systematic review.
   Eur J Surg Oncol. 2025;51:110343.
   PubMed     Abstract available
   
   
   
6. TIAN Z, Zhang Y, Cheng Y, Wang D, et al
   Long-term muscle-sparing benefits of proximal gastrectomy in elderly patients with upper-third early gastric cancer: A propensity score-matched analysis.
   Eur J Surg Oncol. 2025;51:110373.
   PubMed     Abstract available
   
   
   
7. YEN HH, Lin YJ, Huang CC, Yeh CC, et al
   Oncological and functional outcomes of proximal versus total gastrectomy for advanced proximal gastric cancer: A propensity score-matched study.
   Eur J Surg Oncol. 2025;51:110370.
   PubMed     Abstract available
   
   
   
8. ZHANG HX, Huang ZN, Zhang XQ, Tang YH, et al
   Enhancing prognostic accuracy in gastric cancer: The TNrrM staging system versus the AJCC TNM system.
   Eur J Surg Oncol. 2025;51:110362.
   PubMed     Abstract available
   
   
   
9. HWANG J, Moon J, Kim KY, Park SH, et al
   Enhanced recovery and comparable long-term outcomes in reduced-port robotic distal gastrectomy versus conventional laparoscopic distal gastrectomy: A propensity score-matched analysis of single-center experience.
   Eur J Surg Oncol. 2025;51:110137.
   PubMed     Abstract available
   
   
   
10. BENARD F, Marcil S, Mack L, Deban M, et al
    Survival outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in selected patients with stage IV gastric adenocarcinoma - A Canadian case series.
    Eur J Surg Oncol. 2025;51:110000.
    PubMed     Abstract available
    
    
    
11. SUI W, Chen P, Chen Z, Han W, et al
    Construction of nomogram prognostic model for gastric signet ring cell carcinoma: Signet ring cell proportion influencing prognosis.
    Eur J Surg Oncol. 2025;51:110012.
    PubMed     Abstract available
    
    
    
12. WANG J, de Jongh C, Wu Z, de Groot EM, et al
    Impact of pre-treatment waiting intervals on short-term postoperative outcomes in neoadjuvant chemotherapy followed by gastrectomy: A population-based study using the Dutch Upper Gastrointestinal Cancer Audit (DUCA) data.
    Eur J Surg Oncol. 2025;51:109595.
    PubMed     Abstract available
    
    
    July 2025
13. TIAN P, Chen Z, Fang B, Wang X, et al
    Investigating the relationship between tongue diagnosis features and gastric cancer: A machine learning-based prediction model.
    Eur J Surg Oncol. 2025;51:110352.
    PubMed     Abstract available
    
    
    
14. TRIEMSTRA L, de Jongh C, Brenkman HJF, Weusten BLAM, et al
    Implementing robot-assisted minimally invasive gastrectomy (RAMIG) for gastric cancer in a European tertiary referral center.
    Eur J Surg Oncol. 2025;51:110342.
    PubMed     Abstract available
    
    
    
15. LI H
    Reply to ChatGPT-4o outperforms Gemini advanced in assisting multidisciplinary decision-making for advanced gastric cancer.
    Eur J Surg Oncol. 2025;51:110217.
    PubMed    
    
    
    
16. QIU WW, Huang ZN, Li TY, Zhang L, et al
    Comparison of short- and mid-term outcomes of robotic versus laparoscopic gastrectomy in high-risk patients with gastric cancer: a nationwide, multicentre cohort study.
    Eur J Surg Oncol. 2025;51:110294.
    PubMed     Abstract available
    
    
    
17. TAN S, Yang G
    Surgical resection for small (
    Eur J Surg Oncol. 2025;51:109998.
    PubMed     Abstract available
    
    
    June 2025
18. DENG Y, He LJ, Li X
    Robotic versus laparoscopic gastrectomy for gastric cancer in asia: A meta-analysis of short-term outcomes from six randomized controlled trials.
    Eur J Surg Oncol. 2025;51:110298.
    PubMed     Abstract available
    
    
    
19. YU D, Chen W, Zhang F, Huang H, et al
    Laparoscopic radical gastrectomy is a protective factor for clinical outcomes in gastric cancer patients with sarcopenia.
    Eur J Surg Oncol. 2025 Jun 27:110299. doi: 10.1016/j.ejso.2025.110299.
    PubMed     Abstract available
    
    
    
20. SHEIKH MI, Shahzad UB, Ahmed M
    Prognostic implications of signet ring cell proportion in gastric cancer: Insights from a novel nomogram and biomarker analysis.
    Eur J Surg Oncol. 2025;51:110245.
    PubMed    
    
    
    
21. WANG SL, Chen CB, Huang YS, Ruan XJ, et al
    Muscle-specific strength is an alternative to muscle mass and grip strength for predicting outcomes in patients with gastric cancer.
    Eur J Surg Oncol. 2025;51:110229.
    PubMed     Abstract available
    
    
    
22. CHENG Y, Tian Z, Zhou J, Zhao S, et al
    Evaluation of combined tubular gastroesophageal anastomosis and C-shaped flap technique in proximal gastrectomy for gastric cancer: A retrospective propensity score matching analysis.
    Eur J Surg Oncol. 2025;51:110227.
    PubMed     Abstract available
    
    
    
23. DAUNGSUPAWONG H, Wiwanitkit V
    RE: ChatGPT-4o outperforms gemini advanced in assisting multidisciplinary decision-making for advanced gastric cancer.
    Eur J Surg Oncol. 2025;51:110218.
    PubMed    
    
    
    
24. MARIANI A, Triantafyllou E, Kepenekian V, Zaanan A, et al
    Management of peritoneal gastric metastasis: An update.
    Eur J Surg Oncol. 2025;51:109731.
    PubMed     Abstract available
    
    
    
25. JEONG JY, Yoon JK, Hwang J, Park SH, et al
    Diagnostic performance of fluorescent lymphography-guided lymph node dissection during minimally invasive gastrectomy following chemotherapy.
    Eur J Surg Oncol. 2025;51:109738.
    PubMed     Abstract available
    
    
    
26. GREGERSEN JS, Solstad TU, Achiam MP, Olsen AA, et al
    Textbook outcome and textbook oncological outcome in esophagogastric cancer surgery - A systematic scoping review.
    Eur J Surg Oncol. 2025;51:109672.
    PubMed     Abstract available
    
    
    May 2025
27. VIVIAN CHIU SW, Tsai YN, Ker CY, Chiu CC, et al
    Comment on "Lymph node metastasis prediction model for each lymph node station in gastric cancer patients".
    Eur J Surg Oncol. 2025;51:110189.
    PubMed    
    
    
    
28. KARIMI AM, Khosravi A, Masoudi N
    Re: Optimizing surgical timing following neoadjuvant therapy for gastric cancer: Insights from a multicenter retrospective analysis.
    Eur J Surg Oncol. 2025;51:110171.
    PubMed    
    
    
    
29. CHEN J, Liu F
    Reply to: Re: Optimizing surgical timing following neoadjuvant therapy for gastric cancer: Insights from a multicenter retrospective analysis.
    Eur J Surg Oncol. 2025;51:110170.
    PubMed    
    
    
    
30. YEE EJ, Stuart CM, Kim S, McCarter MD, et al
    Impact of socioeconomic determinants of health on delays to care in gastric cancer: A national cancer database analysis.
    Eur J Surg Oncol. 2025;51:110136.
    PubMed     Abstract available
    
    
    
31. AALTONEN P, Mustonen H, Puolakkainen P, Haglund C, et al
    Incidence and prognostic role of venous thromboembolism in gastric cancer: a nationwide Finnish register study.
    Eur J Surg Oncol. 2025;51:110139.
    PubMed     Abstract available
    
    
    
32. LIU Z, Yang F, Hao Y, Jiang Q, et al
    A nomogram for predicting the risk of liver metastasis in non-functional neuroendocrine neoplasms: A population-based study.
    Eur J Surg Oncol. 2025;51:109708.
    PubMed     Abstract available
    
    
    
33. CHEN Y, Zhu X, Ding S, Chen M, et al
    Minimally invasive treatment strategies for submucosal tumors of the upper gastrointestinal tract: Advances in innovative endoscopy-based therapies.
    Eur J Surg Oncol. 2025;51:109626.
    PubMed     Abstract available
    
    
    
34. BUTTERWORTH JW, Boshier PR, Mavroveli S, Reynolds JV, et al
    A proposed framework of strategies to overcome challenges to surgical quality assurance in oncology trials (SQA-Onc.).
    Eur J Surg Oncol. 2025;51:109593.
    PubMed     Abstract available
    
    
    
35. WHITE C, Jayaprakasam VS, Tenet M, Tang LH, et al
    PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinoma.
    Eur J Surg Oncol. 2025;51:109589.
    PubMed     Abstract available
    
    
    April 2025
36. TOPKAN E, Ozturk D, Selek U
    Letter to the editor: The impact of preoperative skeletal muscle mass index-defined sarcopenia on postoperative complications and survival in gastric cancer: An updated meta-analysis.
    Eur J Surg Oncol. 2025;51:110113.
    PubMed    
    
    
    
37. SHANG-GUAN ZX, Zhong Q, Zhang ZQ, Liu ZY, et al
    Surgical and oncological outcomes of laparoscopic versus open gastrectomy after neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter analysis.
    Eur J Surg Oncol. 2025;51:110060.
    PubMed     Abstract available
    
    
    
38. LI H, Huang J, Liu K, Liu J, et al
    ChatGPT-4o outperforms gemini advanced in assisting multidisciplinary decision-making for advanced gastric cancer.
    Eur J Surg Oncol. 2025;51:110096.
    PubMed     Abstract available
    
    
    
39. CHEN J, Hu K, Lu J, Pan H, et al
    Optimizing surgical timing following neoadjuvant therapy for gastric Cancer: Insights from a multicenter retrospective analysis.
    Eur J Surg Oncol. 2025;51:110063.
    PubMed     Abstract available
    
    
    
40. AMEYA KP, Sekar D
    Letter to the editor: Outcomes of intraperitoneal chemotherapy for the treatment of gastric cancer with peritoneal metastasis: A comprehensive systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:110026.
    PubMed    
    
    
    
41. CHO YS, Berlth F, Kim J, Suh YS, et al
    Clinical outcomes of robotic and laparoscopic gastrectomy using propensity score matching method: Data of 5-year period in a Korean high-volume gastric cancer center.
    Eur J Surg Oncol. 2025;51:110014.
    PubMed     Abstract available
    
    
    
42. LIU Y, Chen Y, Shu J, Zhang Z, et al
    Dual-energy CT for predicting progression-free survival of locally advanced gastric cancer after gastrectomy: Insights into tumor angiogenesis.
    Eur J Surg Oncol. 2025;51:110017.
    PubMed     Abstract available
    
    
    March 2025
43. SEDLAK K, Kubiak M, Pelc Z, Mlak R, et al
    Corrigendum to "Prime suspect or collective responsibility: Impact of specific lymph node station dissection on short- and long-term outcomes among locally advanced gastric cancer patients after neoadjuvant chemotherapy" [Eur J Surg Oncol 51 (2025) 10
    Eur J Surg Oncol. 2025 Mar 21:109975. doi: 10.1016/j.ejso.2025.109975.
    PubMed    
    
    
    
44. MATSUI R, Ohashi M, Ri M, Makuuchi R, et al
    Worse oncological impact of preoperative anemia in patients with locally advanced gastric cancer after curative gastrectomy: A retrospective cohort study.
    Eur J Surg Oncol. 2025;51:109762.
    PubMed     Abstract available
    
    
    
45. XING J, Wang Y, Cao M, Shan F, et al
    Identifying potential beneficiaries of neoadjuvant therapy in borrmann type III and IV gastric cancer: A treatment heterogeneity analysis using causal survival forests.
    Eur J Surg Oncol. 2025;51:109752.
    PubMed     Abstract available
    
    
    
46. XIE RZ, Huang ZN, Zhang XQ, Sun YQ, et al
    Long-term survival analysis after radical gastrectomy for Epstein-Barr virus-associated gastric cancer: A multicenter study.
    Eur J Surg Oncol. 2025;51:109737.
    PubMed     Abstract available
    
    
    
47. WONG E, Kamarajah SK, Dahdaleh F, Naffouje S, et al
    Adjuvant chemotherapy for node-negative gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy: A propensity score matched analysis study.
    Eur J Surg Oncol. 2025;51:109506.
    PubMed     Abstract available
    
    
    
48. MATEUSIAK L, Hakuno S, de Jonge-Muller ESM, Floru S, et al
    Fluorescent Nanobodies for enhanced guidance in digestive tumors and liver metastasis surgery.
    Eur J Surg Oncol. 2025;51:109537.
    PubMed     Abstract available
    
    
    February 2025
49. XU R, Li Y, Zhao H, Wang Z, et al
    Tumor deposits in gastric cancer cannot be regarded as metastatic lymph nodes: A single-center retrospective study.
    Eur J Surg Oncol. 2025;51:109719.
    PubMed     Abstract available
    
    
    
50. PUTILA E, Helminen O, Helmio M, Huhta H, et al
    Preoperative predictors of postoperative complications after gastrectomy for gastric cancer, a population-based study in Finland.
    Eur J Surg Oncol. 2025;51:109682.
    PubMed     Abstract available
    
    
    
51. BACOEUR-OUZILLOU O, Voron T, Lambert C, Fuks D, et al
    Impact of obesity on outcomes following surgery for gastric adenocarcinoma: A European multi-institutional study.
    Eur J Surg Oncol. 2025;51:109518.
    PubMed     Abstract available
    
    
    
52. TIAN Z, Cheng Y, Wang Y, Ren J, et al
    A 3-Arm case-matched analysis of anti-reflux reconstruction methods after laparoscopic proximal gastrectomy - Single tract jejunal interposition vs double tract reconstruction vs tube-like stomach reconstruction.
    Eur J Surg Oncol. 2025;51:109482.
    PubMed     Abstract available
    
    
    
53. OGAWA R, Yoshikawa T, Fujisaki Y, Nishino M, et al
    Risk factors for postoperative liver dysfunction in robot-assisted gastrectomy for gastric cancer.
    Eur J Surg Oncol. 2025;51:109668.
    PubMed     Abstract available
    
    
    January 2025
54. VAN DER LINDE M, Visser MR, Eijkenaar F, Oude Voshaar MAH, et al
    Case-mix adjustment for between-hospital comparisons in oesophageal and gastric cancer surgery.
    Eur J Surg Oncol. 2025;51:109644.
    PubMed     Abstract available
    
    
    
55. SEO WJ, Kim DW, Lee CM, Park JY, et al
    Intraperitoneal paclitaxel with systemic S-1 plus oxaliplatin for advanced or recurrent gastric cancer with peritoneal metastasis: A single-arm, multicenter phase II clinical trial.
    Eur J Surg Oncol. 2025;51:109603.
    PubMed     Abstract available
    
    
    
56. KIM JW, Hong H, Park SH, Choi JH, et al
    Lymph node metastasis prediction model for each lymph node station in gastric cancer patients.
    Eur J Surg Oncol. 2025 Jan 10:109590. doi: 10.1016/j.ejso.2025.109590.
    PubMed     Abstract available
    
    
    
57. JOREK N, Weber MC, Kasajima A, Reischl S, et al
    Configuration of anastomotic doughnuts of stapled anastomoses in upper gastrointestinal surgery is associated with anastomotic leakage.
    Eur J Surg Oncol. 2025;51:109460.
    PubMed     Abstract available
    
    
    
58. LIU G, Cao S, Liu X, Tian Y, et al
    Short- and long-term outcomes following perioperative ERAS management in patients undergoing minimally invasive radical gastrectomy after neoadjuvant chemotherapy: A single-center retrospective propensity score matching study.
    Eur J Surg Oncol. 2025;51:109459.
    PubMed     Abstract available
    
    
    December 2024
59. LIU C, Li Y, Xu Y, Hou H, et al
    The impact of preoperative skeletal muscle mass index-defined sarcopenia on postoperative complications and survival in gastric cancer: An updated meta-analysis.
    Eur J Surg Oncol. 2024 Dec 28:109569. doi: 10.1016/j.ejso.2024.109569.
    PubMed     Abstract available
    
    
    
60. SUN Y, Tian Y, Li Z, Cao S, et al
    Multimodal prehabilitation to improve functional abilities and reduce the chronic inflammatory response of frail elderly patients with gastric cancer: A prospective cohort study.
    Eur J Surg Oncol. 2024;51:109563.
    PubMed     Abstract available
    
    
    
61. SEDLAK K, Kubiak M, Pelc Z, Mlak R, et al
    Prime suspect or collective responsibility: Impact of specific lymph node station dissection on short- and long-term outcomes among locally advanced gastric cancer patients after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2024;51:109545.
    PubMed     Abstract available
    
    
    
62. SUN X, Li X, Zhao S, Li C, et al
    Which surrogate endpoint best predict survival in locally advanced gastric cancer patients undergoing neoadjuvant chemoimmunotherapy followed by surgery? A multicenter retrospective study.
    Eur J Surg Oncol. 2024;51:109517.
    PubMed     Abstract available
    
    
    
63. WANG J, Wu Z, Freund JE, de Groot EM, et al
    Comparison between AJCC 8th edition gastric and esophageal ypTNM classification system in Siewert II esophagogastric junction adenocarcinomas: A retrospective study based on Eastern and Western Data.
    Eur J Surg Oncol. 2024;50:108730.
    PubMed     Abstract available
    
    
    
64. EDHOLM D, Linder G, Hedberg J, Rouvelas I, et al
    Perioperative blood transfusions associated with reduced survival in gastroesophageal cancers - A Swedish population-based study.
    Eur J Surg Oncol. 2024;50:108690.
    PubMed     Abstract available
    
    
    
65. DAYANAMBY A, Chmelo J, Bradshaw A, Phillips AW, et al
    Predictors of early recurrence of oesophagogastric adenocarcinoma after neoadjuvant FLOT.
    Eur J Surg Oncol. 2024;50:108657.
    PubMed     Abstract available
    
    
    November 2024
66. WU J, Huang ZN, Zhang XQ, Hou SS, et al
    Development of a modified nutritional index model based on nutritional status and sarcopenia to predict long-term survival and chemotherapy benefits in elderly patients with advanced gastric cancer.
    Eur J Surg Oncol. 2024;51:109503.
    PubMed     Abstract available
    
    
    
67. BOSHIER PR, Tekkis N, Baggaley A, Robb HD, et al
    Outcomes of intraperitoneal chemotherapy for the treatment of gastric cancer with peritoneal metastasis: A comprehensive systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;51:109499.
    PubMed     Abstract available
    
    
    
68. DAT TQ, Thong DQ, Nguyen DT, Hai NV, et al
    Effectiveness of conversion surgery in stage IV gastric cancer.
    Eur J Surg Oncol. 2024;51:109485.
    PubMed     Abstract available
    
    
    
69. HAN L, Zhou Y, Wang Y, Chen H, et al
    Nutritional status of early oral feeding for gastric cancer patients after laparoscopic total gastrectomy: A retrospective cohort study.
    Eur J Surg Oncol. 2024 Nov 12:109379. doi: 10.1016/j.ejso.2024.109379.
    PubMed     Abstract available
    
    
    
70. HE CH, Li ZZ, Ke HW, Zhai WB, et al
    Stair climbing outperforms gait speed in predicting postoperative outcomes in patients undergoing radical gastrectomy for gastric cancer: A prospective study.
    Eur J Surg Oncol. 2024;51:109378.
    PubMed     Abstract available
    
    
    October 2024
71. BHUTIANI N, Seo YD, Robinson KA, White MG, et al
    HIPEC for metastatic gastric cancer: Moving the needle towards 3-year survival.
    Eur J Surg Oncol. 2024;51:108790.
    PubMed     Abstract available
    
    
    
72. KONDO H, Sato S, Kunisaki C, Tanaka Y, et al
    Prognostic factors in patients with pathological T3N0M0 gastric cancer: A multi-institutional, retrospective study (YCOG2202).
    Eur J Surg Oncol. 2024 Oct 23:108782. doi: 10.1016/j.ejso.2024.108782.
    PubMed     Abstract available
    
    
    
73. ZHAO B, Bao L, Zhang T, Chen Y, et al
    Prevalence of sarcopenic obesity in patients with gastric cancer and effects on adverse outcomes: A meta-analysis and systematic review.
    Eur J Surg Oncol. 2024;50:108772.
    PubMed     Abstract available
    
    
    
74. FUJISAKI YY, Yoshikawa T, Ogawa R, Nishino M, et al
    Necessity of splenectomy for antral-type scirrhous gastric cancer.
    Eur J Surg Oncol. 2024 Oct 6:108734. doi: 10.1016/j.ejso.2024.108734.
    PubMed     Abstract available
    
    
    September 2024
75. NAGATA H, Kinoshita T, Komatsu M, Habu T, et al
    Comparison of robotic versus laparoscopic total gastrectomy for gastric cancer: A single-center retrospective cohort study in a Japanese high-volume center.
    Eur J Surg Oncol. 2024;50:108706.
    PubMed     Abstract available
    
    
    
76. ZHENG H, Zheng H, Wei L, Xue Z, et al
    Risk stratification models incorporating oxidative stress factors to predict survival and recurrence in patients with gastric cancer after radical gastrectomy: A real-world multicenter study.
    Eur J Surg Oncol. 2024;50:108658.
    PubMed     Abstract available
    
    
    
77. VAN DER BURG SJ, Bleckman RF, van der Sluis PC, Hartgrink HH, et al
    Improvement of perioperative outcomes of gastric gastrointestinal stromal tumour (GIST) resections and the influence of minimal invasive surgery.
    Eur J Surg Oncol. 2024;50:108479.
    PubMed     Abstract available
    
    
    
78. DUMONT F, Kepenekian V, Passot C, Ezanno-Manasterski AC, et al
    PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial.
    Eur J Surg Oncol. 2024;50:108468.
    PubMed     Abstract available
    
    
    
79. HUANG Z, Huang Y, Huang C, Li P, et al
    Reply to: Chemotherapy benefits in patients with hepatoid adenocarcinoma: A long-term follow-up study on a rare gastric disease.
    Eur J Surg Oncol. 2024;50:108407.
    PubMed    
    
    
    August 2024
80. TAKAHASHI K, Terashima M, Notsu A, Koseki Y, et al
    Surgical treatment for liver metastasis from gastric cancer: A systematic review and meta-analysis of long-term outcomes and prognostic factors.
    Eur J Surg Oncol. 2024;50:108582.
    PubMed     Abstract available
    
    
    
81. WEI S, Yu S
    Reevaluating surgical margins in gastric cancer: Addressing the impact of close resection margins and BMI classification on prognosis.
    Eur J Surg Oncol. 2024 Aug 6:108574. doi: 10.1016/j.ejso.2024.108574.
    PubMed    
    
    
    
82. PARK JY, Park KB, Kwon OK
    Reply to: Reevaluating surgical margins in gastric cancer: Addressing the impact of close resection margins and BMI classification on prognosis.
    Eur J Surg Oncol. 2024 Aug 3:108575. doi: 10.1016/j.ejso.2024.108575.
    PubMed    
    
    
    
83. WANG SL, Zhang FM, Chen CB, Dong QT, et al
    Comparison between AWGC-cachexia and GLIM-malnutrition in patients with gastric cancer.
    Eur J Surg Oncol. 2024;50:108580.
    PubMed     Abstract available
    
    
    
84. VAN DER SLUIS K, Vollebergh MA, Kodach LL, van Dieren JM, et al
    The clinical implications of staging laparoscopy in the diagnostic workup of gastric cancer patients: A population based study.
    Eur J Surg Oncol. 2024;50:108569.
    PubMed     Abstract available
    
    
    July 2024
85. ITAMI T, Kurokawa Y, Yoshioka R, Saito T, et al
    Measuring serum and drainage fluid interleukin-6 and tumor necrosis factor-alpha levels for early detection of infectious complications after minimally invasive surgery for gastric cancer.
    Eur J Surg Oncol. 2024;50:108564.
    PubMed     Abstract available
    
    
    
86. HERRERA KOK JH, Marano L, van den Berg JW, Shetty P, et al
    Current trends in the management of Gastro-oEsophageal cancers: Updates to the ESSO core curriculum (ESSO-ETC-UGI-WG initiative).
    Eur J Surg Oncol. 2024;50:108387.
    PubMed     Abstract available
    
    
    
87. ALEMDAR A, Duman MG, Sengiz Erhan S, Sasako M, et al
    Histopathologic response in patients with curative resection with D2 dissection following neoadjuvant treatment for locally advanced gastric and esophagogastric junction adenocarcinoma.
    Eur J Surg Oncol. 2024;50:108428.
    PubMed     Abstract available
    
    
    June 2024
88. PARK JY, Yang JY, Park KB, Kwon OK, et al
    Prognostic effect of microscopically negative but close resection margin in gastric cancer.
    Eur J Surg Oncol. 2024;50:108517.
    PubMed     Abstract available
    
    
    
89. AAMIR N, Waqar SA
    Letter to the editor 'Staging laparoscopy with peritoneal lavage to identify peritoneal metastases and free intraperitoneal cancer cells in the management of locally advanced gastric cancer'.
    Eur J Surg Oncol. 2024;50:108466.
    PubMed    
    
    
    
90. CHAI Y, Lin B, Zhong J, Wu X, et al
    Long-term outcomes of endoscopic therapy versus surgical resection for 2-5 cm gastric gastrointestinal stromal tumors: A population-based comparative study.
    Eur J Surg Oncol. 2024;50:108262.
    PubMed     Abstract available
    
    
    May 2024
91. MANSOOR M, Ahmed M, Manzoor I
    "Shaping gastric cancer outcomes: Advancing diagnosis and treatment through staging laparoscopy in peritoneal Metastasis detection".
    Eur J Surg Oncol. 2024;50:108448.
    PubMed    
    
    
    April 2024
92. ZHANG LK, Zheng HL, Zheng HH, Ma YB, et al
    Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2024;50:108367.
    PubMed     Abstract available
    
    
    
93. BELIA F, Kim KY, Agnes A, Park SH, et al
    Predicting peritoneal recurrence after radical gastrectomy for gastric cancer: Validation of a prediction model (PERI-Gastric 1 and PERI-Gastric 2) on a Korean database.
    Eur J Surg Oncol. 2024;50:108359.
    PubMed     Abstract available
    
    
    
94. BHANDARE MS, Gundavda KK, Yelamanchi R, Chopde A, et al
    Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: Analysis of 1001 cases.
    Eur J Surg Oncol. 2024;50:108343.
    PubMed     Abstract available
    
    
    
95. COSTA PMD, Antunes C, Lages P, Rodrigues J, et al
    Challenging the Dogma: Stage migration or negative lymph nodes, which of them is the main player on gastric cancer prognosis?
    Eur J Surg Oncol. 2024;50:108318.
    PubMed     Abstract available
    
    
    
96. SHEEN AR, Saqib HWU
    "Harnessing AI for treatment optimization: Neoadjuvant chemotherapy in gastroesophageal cancer".
    Eur J Surg Oncol. 2024;50:108228.
    PubMed    
    
    
    
97. KUHLEN M, Kunstreich M, Pape UF, Seitz G, et al
    Lymph node metastases are more frequent in paediatric appendiceal NET >/=1.5 cm but without impact on outcome - Data from the German MET studies.
    Eur J Surg Oncol. 2024;50:108051.
    PubMed     Abstract available
    
    
    
98. VAN HOOTEGEM SJM, Chmelo J, van der Sluis PC, Lagarde SM, et al
    The yield of diagnostic laparoscopy with peritoneal lavage in gastric adenocarcinoma: A retrospective cohort study.
    Eur J Surg Oncol. 2024;50:108233.
    PubMed     Abstract available
    
    
    
99. MAURER CA, Walensi M, Mattiello D, Kaser SA, et al
    Intraoperative esophageal washout reduces free intraluminal tumor cells during resection of carcinomas of the esophagus and cardia.
    Eur J Surg Oncol. 2024;50:108017.
    PubMed     Abstract available
    
    
    March 2024
100. HUANG ZN, Zheng CY, Wu J, Tang YH, et al
     Textbook oncological outcomes and prognosis after curative gastrectomy in advanced gastric cancer: A multicenter study.
     Eur J Surg Oncol. 2024;50:108280.
     PubMed     Abstract available
     
     
     
101. VAN DER SLUIS K, Guchelaar NAD, Triemstra L, Mathijssen RHJ, et al
     Staging laparoscopy in gastric cancer patients: From a Dutch nationwide Delphi consensus towards a standardized protocol.
     Eur J Surg Oncol. 2024;50:108278.
     PubMed     Abstract available
     
     
     
102. HUANG B, Rampulla V, Ri M, Lindblad M, et al
     Staging laparoscopy with peritoneal lavage to identify peritoneal metastases and free intraperitoneal cancer cells in the management of locally advanced gastric cancer.
     Eur J Surg Oncol. 2024;50:108059.
     PubMed     Abstract available
     
     
     
103. LIN X, Tan C, Wu W, Liang C, et al
     Evaluation of factors influencing long-term and textbook outcomes in laparoscopic gastrectomy.
     Eur J Surg Oncol. 2024;50:108002.
     PubMed     Abstract available
     
     
     February 2024
104. NOOR Z, Gossage J, Evans O, Cuffe R, et al
     Unmet needs in survivorship: Increased anxiety post oesophago-gastric cancer surgery.
     Eur J Surg Oncol. 2024;50:108046.
     PubMed     Abstract available
     
     
     
105. LI J, Chen X, Xu S, Wang Y, et al
     Predicting pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer: The establishment of a spectral CT-based nomogram from prospective datasets.
     Eur J Surg Oncol. 2024;50:108020.
     PubMed     Abstract available
     
     
     
106. ZHENG HL, Wei LH, Xu BB, Zheng HH, et al
     Prognostic value of preoperative sarcopenia in gastric cancer: A 10-year follow-up study.
     Eur J Surg Oncol. 2024;50:108004.
     PubMed     Abstract available
     
     
     January 2024
107. TAKI Y, Ito S, Mizusawa J, Yura M, et al
     Risk factors for abdominal surgical infectious complications after distal gastrectomy for gastric cancer: A post-hoc analysis of a randomized controlled trial (JCOG0912).
     Eur J Surg Oncol. 2024;50:107982.
     PubMed     Abstract available
     
     
     December 2023
108. MIAO X, Guo Y, Chen Y, Xu X, et al
     Exploration of frailty trajectories and their associations with health outcomes in older gastric cancer survivors undergoing radical gastrectomy: A prospective longitudinal observation study.
     Eur J Surg Oncol. 2023;50:107934.
     PubMed     Abstract available
     
     
     
109. YAO GL, Tao YJ, Fan YG
     Cutaneous metastasis from gastric cancer: Manifestation, diagnosis, treatment and prognosis.
     Eur J Surg Oncol. 2023;50:107939.
     PubMed     Abstract available
     
     
     
110. MENG C, Cao S, Yu Q, Tian Y, et al
     Short- and long-term comparison of robotic versus laparoscopic gastrectomy for gastric cancer patients with BMI>/=30 kg/m(2): A propensity score matched analysis.
     Eur J Surg Oncol. 2023;50:107312.
     PubMed     Abstract available
     
     
     
111. HOJO Y, Ishida Y, Tomita T, Kurahashi Y, et al
     Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer.
     Eur J Surg Oncol. 2023;50:107314.
     PubMed     Abstract available
     
     
     
112. TRIEMSTRA L, de Jongh C, Tedone F, Brosens LAA, et al
     The Comprehensive Complication Index versus Clavien-Dindo grading after laparoscopic and open D2-gastrectomy in the multicenter randomized LOGICA-trial.
     Eur J Surg Oncol. 2023;49:107095.
     PubMed     Abstract available
     
     
     November 2023
113. MINISTRINI S, Bencivenga M, Filippini F, Mura G, et al
     A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series.
     Eur J Surg Oncol. 2023;50:107275.
     PubMed     Abstract available
     
     
     
114. HOLMEN A, Jebril W, Ida S, Agustsson T, et al
     Effects of neoadjuvant therapy on health-related quality of life for patients with gastroesophageal cancer.
     Eur J Surg Oncol. 2023;49:107008.
     PubMed     Abstract available
     
     
     
115. KANG MK, Kim J, Choi JH, Choe HN, et al
     Can prospective monitoring improve complication rates after gastrectomy? Experience of Billroth I reconstruction at a high-volume tertiary center.
     Eur J Surg Oncol. 2023;49:106985.
     PubMed     Abstract available
     
     
     
116. HUANG ZN, Huang YQ, Hong QQ, Zhang P, et al
     Long-term prognostic benefit of adjuvant chemotherapy for patients with hepatoid adenocarcinoma of the stomach after radical resection: A national multicenter study.
     Eur J Surg Oncol. 2023;49:106975.
     PubMed     Abstract available
     
     
     
117. SALAVATIZADEH M, Soltanieh S, Radkhah N, Ataei Kachouei AH, et al
     The association between skeletal muscle mass index (SMI) and survival after gastrectomy: A systematic review and meta-analysis of cohort studies.
     Eur J Surg Oncol. 2023;49:106980.
     PubMed     Abstract available
     
     
     October 2023
118. ZHANG J, Cao X, Dai N, Zhu S, et al
     Efficacy analysis of endoscopic treatment of giant gastric gastrointestinal stromal tumors (>/=5 cm).
     Eur J Surg Oncol. 2023;49:106955.
     PubMed     Abstract available
     
     
     
119. WITHEY SJ, Owczarczyk K, Grzeda MT, Yip C, et al
     Association of dynamic contrast-enhanced MRI and (18)F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer.
     Eur J Surg Oncol. 2023;49:106934.
     PubMed     Abstract available
     
     
     September 2023
120. ZHENG CY, Wu J, Chen CS, Huang ZN, et al
     A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter study.
     Eur J Surg Oncol. 2023;49:107094.
     PubMed     Abstract available
     
     
     
121. ZHOU M, Zhong G, Sun H, Zhu Q, et al
     Risk factors for postoperative pancreatic fistula (POPF) in gastric cancer patients: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2023;49:107092.
     PubMed     Abstract available
     
     
     
122. REIS ME, Ulusahin M, Cekic AB, Usta MA, et al
     Does surgeon specialization add value to surgeon volume in gastric cancer surgery?
     Eur J Surg Oncol. 2023;49:107091.
     PubMed     Abstract available
     
     
     
123. IKEGAME K, Hatakeyama K, Terashima M, Sugino T, et al
     Molecular profiling of gastric neuroendocrine carcinomas.
     Eur J Surg Oncol. 2023;49:106987.
     PubMed     Abstract available
     
     
     
124. LUIJTEN JCHBM, Vissers PAJ, Geerts J, Lemmens VEP, et al
     Hospital practice variation in the proportion of patients with esophagogastric cancer discussed during an expert multidisciplinary team meeting.
     Eur J Surg Oncol. 2023;49:106880.
     PubMed     Abstract available
     
     
     
125. LIN X, Tan C, Li Z, Wu W, et al
     Long-term oncologic and surgical outcomes of robotic and laparoscopic gastrectomy for Siewert II/III esophagogastric junction carcinoma: A propensity score-matched retrospective cohort study.
     Eur J Surg Oncol. 2023;49:106898.
     PubMed     Abstract available
     
     
     
126. FUNK-DEBLEDS P, Rossi J, Bernard L, Galan A, et al
     Post-operative weight loss affects 3-year survival in patients with gastric adenocarcinoma after gastrectomy and hyperthermic intraperitoneal chemotherapy.
     Eur J Surg Oncol. 2023;49:106895.
     PubMed     Abstract available
     
     
     August 2023
127. DE JONGH C, Triemstra L, van der Veen A, Brosens LA, et al
     Surgical quality and prospective quality control of the D2-gastrectomy for gastric cancer in the multicenter randomized LOGICA-trial.
     Eur J Surg Oncol. 2023;49:107018.
     PubMed     Abstract available
     
     
     June 2023
128. BIONDI A, Lorenzon L, Santoro G, Agnes A, et al
     Profiling complete regression after pre-operative therapy in gastric cancer patients using clinical and pathological data.
     Eur J Surg Oncol. 2023 Jun 30:S0748-7983(23)00561.
     PubMed     Abstract available
     
     
     March 2023
129. HERRERA-KOK JH, Parmar C, Bangash AH, Samadov E, et al
     Global impact of COVID-19 pandemic on gastric cancer patients.
     Eur J Surg Oncol. 2023 Mar 2:S0748-7983(23)00170.
     PubMed    
     
     
     January 2023
130. ZHENG HL, Lin J, Shen LL, Yang HB, et al
     The GLIM criteria as an effective tool for survival prediction in gastric cancer patients.
     Eur J Surg Oncol. 2023 Jan 12:S0748-7983(23)00031.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.